A Resource for Healthcare and Social Services Professionals
Information impacts action: Debunking myths about the family and recovery
"Information impacts action: Debunking myths about the family and recovery" is a three-minute explainer video written by Matthew Heerema, MS and Alicia Ventura, MPH that challenges long-standing myths and assumptions about family members impacted by a loved one's substance use.
Protecting the Community and Serving Your Patient: The Importance of Buprenorphine
"Protecting the Community and Serving Your Patient: The Importance of Buprenorphine" is Part 3 of 3 in the "Best Practices for Community Pharmacy-Based Care for Patients with Opioid Use Disorder" series. Part 3 describes the three medications that are mainly used for treating Opioid-Use Disorder and dives deeper into buprenorphine prescribing and the pharmacy's role in it. Please note that this training is available for pharmacy credits under our pre-recorded trainings tab.
Community-Centered Care for People Who Use Drugs
"Community-Centered Care for People Who Use Drugs" is Part 2 of 3 in the "Best Practices for Community Pharmacy-Based Care for Patients with Opioid Use Disorder" series. Part 2 focuses on harm reduction practices that can be beneficial to individuals who use drugs and how pharmacies can play a role in these practices. Naloxone and Naloxone distribution will be discussed as well as how safer injection promotion can benefit the overall well-being of patients who use drugs. Please note that this training is available for pharmacy credits under our pre-recorded trainings tab.
Opioid use Disorder - Making Connections
"Opioid use Disorder - Making Connections" is Part 1 of 3 in the "Best Practices for Community Pharmacy-Based Care for Patients with Opioid Use Disorder" series. Part 1 will describe how addiction is a complex chronic illness that requires treatment, often involving medications. This training covers the different types of medications that individuals with Opioid Use Disorders (OUD) might be prescribed. Part 1 will also investigate how stigma impacts the recovery of individuals with Substance Use Disorders. Please note that this training is available for pharmacy credits under our pre-recorded trainings tab.
Waiver-trained: now what? The nuts and bolts of addiction treatment
The new video “Waiver-trained: now what? The nuts and bolts of addiction treatment” is here! This video is intended to help provide waivered prescribers the skills needed to actually implement office-based addiction treatment into an ambulatory practice setting. Additionally, this talk will provide expert, concrete tips to facilitate the provision of care for patients with substance use disorders utilizing medications in their treatment. It is intended to help prescribers looking to increase provision of care for patients with substance use disorder in an outpatient setting.
Extended-Release Buprenorphine: An Instructional Guide
Extended-Release Buprenorphine: An Instructional Guide illustrates clinical pearls and step-by-step administration of extended-release buprenorphine (Sublocade®) based on the experience of clinicians at Boston Medical Center’s Office Based Addiction Treatment Program. The video reflects the security, storage, and handling requirements of the U.S. Drug Enforcement Agency, Massachusetts state law, and Boston Medical Center hospital policy
Substance Use Disorder 101: The Overview
Demystifying Bacterial Infections in Patients with Substance Use Disorders
Written by Simeon Kimmel, MD, MA, Assistant Professor of Medicine at Boston University School of Medicine and Medical Director, BMC Project TRUST
Medications for Treatment of Alcohol Use Disorder
Written by Richard Saitz, MD, MPH, Professor of Medicine at Boston University School of Medicine and Chair and Professor of Community Health Sciences at Boston University School of Public Health
Common Dilemmas in the Ethical Treatment of Inpatients with Substance Use Disorders
Written by Zoe Weinstein, MD, MSc, Director of the BMC Addiction Consult Service and Assistant Professor of Medicine at Boston University School of Medicine
Initiation of Buprenorphine in Patients who are NOT Opioid Dependent
Written by Kristin Wason, MSN, AGPCNP, CARN, Clinical Nurse Educator, BMC OBAT TTA
Reducing the Harms of Incarceration for People with Opioid Use Disorder
Written by Jonathan M. Giftos, MD, Clinical Assistant Professor of Medicine, Albert Einstein College of Medicine, and featuring Karen Hannon, BSN, RN, LADAC II, CARN, Nurse Manager and Corrections Liaison, BMC OBAT.
Methadone and the risk of prolonged QTc Interval – A risk/benefit discussion
Written by Bradley M. Buchheit, MD, MS, Assistant Professor of Medicine and Family Medicine, Oregon Health and Science University
HIV Prevention in People Who Inject Drugs: PrEP and PEP
Written by Jessica Taylor, MD, Assistant Professor at Boston University School of Medicine and Medical Director, Faster Paths to Treatment, Boston Medical Center
Be Prepared: Develop an Overdose Response Plan
Written by Donna Beers, MSN, RN-BC, CARN, Associate Director of the HEALing Communities Study Massachusetts; Gabriel Wishik, MD, MPH, Instructor of Medicine at Boston University School of Medicine; and Alicia Ventura, MPH, Director of Special Projects and Research, BMC OBAT TTA.
Educating Clients on Safer Injection Practices
Written by Gabriel Wishik, MD, MPH, Instructor of Medicine at Boston University School of Medicine
Caring for Young Adults with Substance Use Disorder
Written by Scott Hadland, MD, MPH, MS, pediatrician at Boston Medical Center and Associate Professor of Pediatrics at Boston University School of Medicine.
The Unmet Need for Family Planning Services in Addiction Treatment Settings
Written by Annie L. Potter, MSN, MPH, NP, CARN-AP, nurse practitioner and Clinical Nurse Educator, BMC OBAT TTA.
Tell Me What to Say: How to Approach Challenging Patient Conversations
Written by Lexie Bergeron, MPH, LCSW, Program Director, BMC OBAT TTA
Polysubstance Use: The Norm Not The Exception
Written by Alexander Y. Walley, MD, MSc, Associate Professor of Medicine at Boston University School of Medicine.
Intersection of Pain and Addiction
Written by Daniel Alford, MD, MPH, Director of Boston Medical Center's Clinical Addiction Research and Education Unit and the SCOPE of Pain program.
Addiction Impacts the Entire Family: Pearls for Providers
Written by Alicia S. Ventura, MPH, Director of Special Projects and Research, BMC OBAT TTA
Dr. Ayana Jordan: "COVID-19 is Terrible, But I am More Likely to Die From Structural Racism"
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.